Xylo Technologies Ltd. Cash Flow Conversion Efficiency
Xylo Technologies Ltd. cash flow conversion efficiency. Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) has a cash flow conversion efficiency ratio of -0.008x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-120.00K) by net assets ($15.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Xylo Technologies Ltd. (2016–2024)
Cash flow conversion efficiency of Xylo Technologies Ltd. from 2016 to 2024. This chart illustrates how Xylo Technologies Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Xylo Technologies Ltd. (XYLO) stock price for real-time trading data and today's change.
Xylo Technologies Ltd. Cash Flow Conversion Ratio Explained
Xylo Technologies Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Xylo Technologies Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xylo Technologies Ltd. ranked by their cash flow conversion efficiency. Also see XYLO market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Foresight Group Holdings Limited
LSE:FSG
|
0.305x |
|
Aurora Spine Corp
V:ASG
|
-0.062x |
|
SARAMA RESOURCES LTD
F:48S1
|
0.464x |
|
Bloomsbury Publishing Plc
LSE:BMY
|
0.183x |
|
Saxlund Group AB
ST:SAXG
|
-0.028x |
|
EXPLOITS DISCOVERY CORP.
F:634
|
-0.041x |
|
Aprea Therapeutics Inc
NASDAQ:APRE
|
-0.085x |
|
Hwa Tai Industries Bhd
KLSE:8478
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Xylo Technologies Ltd. from 2016 to 2024. Review Xylo Technologies Ltd. financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $17.59 Million | $-1.82 Million | -0.104x | +46.16% |
| 2023-12-31 | $32.44 Million | $-6.25 Million | -0.193x | -86.23% |
| 2022-12-31 | $54.69 Million | $-5.66 Million | -0.103x | -1.32% |
| 2021-12-31 | $51.43 Million | $-5.25 Million | -0.102x | +56.48% |
| 2020-12-31 | $26.19 Million | $-6.14 Million | -0.235x | +29.24% |
| 2019-12-31 | $8.13 Million | $-2.69 Million | -0.331x | +36.58% |
| 2018-12-31 | $8.08 Million | $-4.22 Million | -0.523x | +38.47% |
| 2017-12-31 | $5.51 Million | $-4.68 Million | -0.849x | +73.18% |
| 2016-12-31 | $2.92 Million | $-9.26 Million | -3.168x | -- |
About Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more